TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Vaccine Année : 2005

TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines

Résumé

The presence of unmethylatedCpGmotifs in bacterial plasmids is thought to provide necessary immunoadjuvant signals toDNAvaccination. We took advantage of CpG-unresponsive toll-like receptor 9 (TLR9) knock-out mice to study whether this pathway was required to generate immune responses to DNA vaccination. We compared two vectors, one encoding the surface glycoprotein C of pseudorabies virus shown to protect target animals against challenge, and the other encoding the cytoplasmic enzyme _-galactosidase. In the absence of TLR9, bone marrow-derived dendritic cells lost their ability to secrete IL-12 and type I IFN in response not only to CpG as expected but also to the plasmids used for vaccination. In contrast, DNA vaccination experiments showed that TLR9-deficient mice were able to mount Th1-biased antigen-specific antibody and IFN-_ responses, albeit at lower levels than normal mice. Thus, TLR9 signaling is not needed for eliciting Tand B-cell responses to DNA encoded antigens. However, TLR9 signaling tended to enhance plasmid-adjuvant effects on antigen-specific immune responses.

Mots clés

Dates et versions

hal-02680528 , version 1 (31-05-2020)

Identifiants

Citer

Daniela Tudor, Catherine C. Dubuquoy, Valérie Gaboriau, Francois F. Lefèvre, Bernard Charley, et al.. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines. Vaccine, 2005, 23 (10), pp.1258-1264. ⟨10.1016/j.vaccine.2004.09.001⟩. ⟨hal-02680528⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More